While single marker analysis using TTF1 recapitulated many of the observations from the initial clusters (Groups 1 and 2), it also identified additional vulnerabilities including greater activity of HSP90 inhibitors in TTF1-low SCLC and of Bcl2 inhibitors in TTF1-high models. Here, TTF1 is linked to small cell lung carcinoma.